-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q3 EPS by 34c ; Offers Guidance
-
-
-
-
-
-
-
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q4 EPS by 39c ; Offers Guidance
-
-
-
-
-
-
-
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024
-
-
-
-
-
-
-
HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q3 EPS by 30c
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q1 EPS by 18c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

